Optimizing Hepatitis B Vaccine Response Through the Use of a Topical Immune Modulator
Clinical trial NCT00175435 · COMPLETED
Trial details
- NCT number
- NCT00175435
- Sponsor
- University of British Columbia
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-08-01
- Primary completion
- 2007-04-01
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.